Bayer CropScience Ltd., the Indian unit of German crop science group Bayer AG, posted a 63.26% decline in its net profit to Rs 34.2 crore in the December 2024 quarter, according to an exchange filing on Wednesday.
The company reported a net profit of Rs 93.1 crore in the year-ago period, according to a regulatory filing. Analysts' estimates compiled by Bloomberg projected a bottomline of Rs 94.2 crore.
Revenue from operations jumped 10.7% to Rs 1,056.90 crore over Rs 954.90 crore in the third quarter of last year. The income was above the Rs 1,037-crore consensus estimate of analysts tracked by Bloomberg.
On the operating side, earnings before interest, tax, depreciation and amortisation fell 85% to Rs 19.70 crore, much lower than the projected Rs 123.90 crore. Margin contracted from 13.4% to 1.9%. The Bloomberg estimate was 12%.
Bayer CropScience Q3 FY25 Highlights (Consolidated, YoY)
Revenue up 10.7% to Rs 1,056.90 crore versus Rs 954.90 crore (Bloomberg Estimate: Rs 1,037 crore).
Ebitda down 85% to Rs 19.70 crore versus Rs 127.90 crore (Bloomberg Estimate: Rs 123.90 crore).
Margin at 1.9% versus 13.4% (Bloomberg Estimate: 12%)
Net profit down 63% to Rs 34.20 crore versus Rs 93.10 crore (Bloomberg Estimate: Rs 94.2 crore).
Simon Britsch, Whole-time Director (Executive) and Chief Financial Officer, said, "Continuing cost efficiency measures were offset by targeted investments in promotional activities as well as provisions for doubtful receivables, attributable to a challenging agricultural economy. We are actively engaged in recovery efforts," in a press release.
Bayer CropScience Share Price Data
Shares of Bayer CropScience closed 8.32% lower on Wednesday at Rs 4,389.50 apiece on the NSE, compared to a 0.12% decline in the benchmark Nifty 50. The company shares have fallen 26.33% in the last 12 months.
Three analysts tracking the company have a 'buy' rating on the stock, five have a 'hold,' and one suggests 'sell,' according to Bloomberg data. The average of 12-month analysts' price targets implies a potential upside of 31.6%.
RECOMMENDED FOR YOU
Bayer CropScience CEO Remains Cautious Over FY26 Outlook Despite Strong Market Potential In India
Sep 03, 2025
Bayer Leverkusen Sacks Erik ten Hag After Just Two Bundesliga Games
Sep 01, 2025
Hindalco Industries Share Price Hits One-Month High As Q1 Net Profit Beats Estimates
Aug 13, 2025
Bayer CropScience Q1 Results: Profit Rises 10%
Aug 06, 2025
POPULAR
